Predictions
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.17
01.05.24
01.05.24
-
-
30.04.24
30.04.24
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€835.40
30.04.24
30.04.24
-
30.04.25
30.04.25
-0.07%
30.04.24
30.04.24
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
28.04.24
28.04.24
-
28.04.25
28.04.25
3.63%
30.04.24
30.04.24
Bad rating
EBIT decline/stagnation expected
Probably not worthwhile Investment
High valuation
Biogen Inc.
Start price
Target price
Perf. (%)
€194.35
27.04.24
27.04.24
€200.00
27.04.25
27.04.25
3.63%
30.04.24
30.04.24
Good rating
Standard Investments for future growth
Innovative
Differentiated customer and product portfolio
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€61.35
26.04.24
26.04.24
€79.45
26.04.25
26.04.25
-0.44%
30.04.24
30.04.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.64
26.04.24
26.04.24
€104.69
26.04.25
26.04.25
0.03%
30.04.24
30.04.24
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€122.60
26.04.24
26.04.24
€133.79
26.04.25
26.04.25
-1.31%
30.04.24
30.04.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€76.58
25.04.24
25.04.24
€102.61
25.04.25
25.04.25
-1.20%
30.04.24
30.04.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.00
25.04.24
25.04.24
€102.63
25.04.25
25.04.25
-1.74%
30.04.24
30.04.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€850.80
24.04.24
24.04.24
€962.84
24.04.25
24.04.25
-1.88%
30.04.24
30.04.24